480 Biomedical’s Stanza™ self-expanding scaffold employs a unique composite design that strikes an optimal balance of strength, flexibility and bioresorption.
Our lead product is the proprietary Stanza™ bioresorbable scaffold and delivery system for use in treating peripheral artery disease in the superficial femoral artery, a condition that is poorly addressed today.
July 9, 2014
Proprietary bioresorbable scaffold technology addresses a critical challenge in treating pediatric cardiovascular conditions
December 11, 2013
480 Biomedical receives its certificate of registration to ISO13485: 2003 for its Quality Management System
October 10, 2012
480 Biomedical Announces Initial Observations from OCT Sub-Study of the STANCE Trial Evaluating the First Self-Expanding Bioresorbable Scaffold for Superficial Femoral Artery Disease
Products presented in this website are not available for sale or distribution and are limited to clinical investigational use only.